Commitments and contingencies disclosure.

No definition available.

Name:	cbio_CommitmentsAndContingenciesDisclosureLineItems
Namespace Prefix:	cbio_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Contingent value rights derivative liability current.

+ References

No definition available.

+ Details

Name:	cbio_ContingentValueRightsDerivativeLiabilityCurrent
Namespace Prefix:	cbio_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Contingent value rights derivative liability non current.

+ References

No definition available.

+ Details

Name:	cbio_ContingentValueRightsDerivativeLiabilityNonCurrent
Namespace Prefix:	cbio_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Cost of services as per agreement.

+ References

No definition available.

+ Details

Name:	cbio_CostOfServicesAsPerAgreement
Namespace Prefix:	cbio_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Distribution from asset sale proceeds.

+ References

No definition available.

+ Details

Name:	cbio_DistributionFromAssetSaleProceeds
Namespace Prefix:	cbio_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Excess amount retained from net proceeds related to disposition of assets.

+ References

No definition available.

+ Details

Name:	cbio_ExcessAmountRetainedFromNetProceedsRelatedToDispositionOfAssets
Namespace Prefix:	cbio_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Number of separate agreements.

+ References

No definition available.

+ Details

Name:	cbio_NumberOfSeparateAgreements
Namespace Prefix:	cbio_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of amount received on agreement, net of expenses.

+ References

No definition available.

+ Details

Name:	cbio_PercentageOfAmountReceivedOnAgreementNetOfExpenses
Namespace Prefix:	cbio_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of excess cash on dispositions net.

+ References

No definition available.

+ Details

Name:	cbio_PercentageOfExcessCashOnDispositionsNet
Namespace Prefix:	cbio_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of excess preapproved costs.

+ References

No definition available.

+ Details

Name:	cbio_PercentageOfExcessPreapprovedCosts
Namespace Prefix:	cbio_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Reimbursement for out-of-pocket fees and expenses.

+ References

No definition available.

+ Details

Name:	cbio_ReimbursementForOutOfPocketFeesAndExpenses
Namespace Prefix:	cbio_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Termination fee required to pay upon termination of agreement.

+ References

No definition available.

+ Details

Name:	cbio_TerminationFeeRequiredToPayUponTerminationOfAgreement
Namespace Prefix:	cbio_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Number of shares of equity interests issued or issuable to acquire entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479581/805-30-50-1

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=cbio_NonGMPManufacturingServicesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=cbio_ClinicalSupplyBatchGMPManufacturingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AssetAcquisitionAxis=cbio_ContingentValueRightsAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=cbio_VertexAssetPurchaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=cbio_FThreeFiveOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=cbio_GNIMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=cbio_BusinessCombinationAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies - Additional Information (Detail)				1 Months Ended	6 Months Ended
	Jun. 05, 2023 USD ($)	Apr. 18, 2023 USD ($) Agreement	Mar. 08, 2023 USD ($)	Mar. 31, 2023 USD ($)	Jun. 30, 2023 USD ($) shares	Feb. 28, 2023 USD ($)	Dec. 31, 2022 USD ($)
Commitments And Contingencies Disclosure [Line Items]
Long-term CVR derivative liability					$ 4,606,000
Number of separate agreements \| Agreement		2
Non GMP Manufacturing Services
Commitments And Contingencies Disclosure [Line Items]
Cost of services as per agreement		$ 300,000			$ 300,000
Clinical Supply Batch GMP Manufacturing
Commitments And Contingencies Disclosure [Line Items]
Cost of services as per agreement		$ 200,000
Contingent Value Rights Agreement
Commitments And Contingencies Disclosure [Line Items]
Percentage of excess cash on dispositions net					100.00%
Percentage of excess cash on dispositions net					$ 1,000,000
Percentage of excess preapproved costs					100.00%
Short-term CVR derivative liability							$ 5,000,000
Long-term CVR derivative liability						$ 4,500,000
Distribution to CVR holders from asset sale proceeds	$ 3,500,000		$ 200,000	$ 200,000
Vertex Asset Purchase Agreement \| Contingent Value Rights Agreement
Commitments And Contingencies Disclosure [Line Items]
Percentage of amount received on agreement, net of expenses					100.00%
F351 \| GNI \| Business Combination Agreement
Commitments And Contingencies Disclosure [Line Items]
Termination fee required to pay upon termination of agreement					$ 2,000,000.0
F351 \| GNI \| Maximum \| Business Combination Agreement
Commitments And Contingencies Disclosure [Line Items]
Common stock, shares issued \| shares					1,110,776,224
Reimbursement for out-of-pocket fees and expenses					$ 2,000,000.0